National Surgical Hospitals Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:National Surgical Hospitals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013354
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
National Surgical Hospitals Inc (NSH) is a healthcare organization that owns, operates and manages surgical facilities. The organization’s management services include operational, clinical, information services, managed care services, legal and compliance services, human resource services, supply chain management and financial services. Its managed care services include market assessments, strategy development, portfolio analysis, payor negotiations, contract modeling and analysis, language review, payer audits, and revenue capture. NSH’s legal services include legal research, contract review and drafting, legal coordination and guidance, litigation defense coordination, dispute resolution, acquisitions and member or partner transactions. The organization serves through surgical hospital and ambulatory surgery center. NSH is headquartered in Chicago, Illinois, the US.

National Surgical Hospitals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
National Surgical Hospitals Inc, Medical Devices Deals, 2011 to YTD 2017 9
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
National Surgical Hospitals Acquires Majority Stake In Lafayette Surgical Specialty Hospital 11
Private Equity 12
Irving Place Capital Acquires National Surgical Hospitals 12
Debt Offering 13
National Surgical Hospitals to Raise up to USD52.5 Million in Private Placement of Notes 13
Acquisition 14
National Surgical Healthcare to Acquire Majority Stake in Optim Healthcare 14
National Surgical Hospitals Acquires Interest in Fairfield Surgery Center 15
National Surgical Hospitals Inc – Key Competitors 16
National Surgical Hospitals Inc – Key Employees 17
National Surgical Hospitals Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Affiliate 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Key Facts 2
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
National Surgical Hospitals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
National Surgical Hospitals Inc, Medical Devices Deals, 2011 to YTD 2017 9
National Surgical Hospitals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
National Surgical Hospitals Acquires Majority Stake In Lafayette Surgical Specialty Hospital 11
Irving Place Capital Acquires National Surgical Hospitals 12
National Surgical Hospitals to Raise up to USD52.5 Million in Private Placement of Notes 13
National Surgical Healthcare to Acquire Majority Stake in Optim Healthcare 14
National Surgical Hospitals Acquires Interest in Fairfield Surgery Center 15
National Surgical Hospitals Inc, Key Competitors 16
National Surgical Hospitals Inc, Key Employees 17
National Surgical Hospitals Inc, Other Locations 18
National Surgical Hospitals Inc, Affiliate 19

★海外企業調査レポート[National Surgical Hospitals Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Exterran Corp (EXTN):企業の財務・戦略的SWOT分析
    Exterran Corp (EXTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • IQVIA Holdings Inc (IQV):企業の財務・戦略的SWOT分析
    IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Enercon GmbH:企業の戦略的SWOT分析
    Enercon GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Shire Plc (SHP):製薬・医療:M&Aディール及び事業提携情報
    Summary Shire Plc (Shire) is a biotechnology company that focuses on the research, development, manufacturing, marketing, distribution and sale of novel pharmaceuticals to treat patients with rare diseases and other highly specialized conditions. It provides products across various therapeutic areas …
  • Kyushu Financial Group Inc (7180):企業の財務・戦略的SWOT分析
    Kyushu Financial Group Inc (7180) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析
    Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • ReNeuron Group Plc (RENE):製薬・医療:M&Aディール及び事業提携情報
    Summary ReNeuron Group Plc (ReNeuron) is a clinical-stage stem cell company which develops innovative stem cell therapies targeting areas of significant unmet medical need. The company’s therapeutic candidates in clinical development are focused at treating motor disability as a result of stroke, cr …
  • Luna Innovations Inc (LUNA):企業の財務・戦略的SWOT分析
    Summary Luna Innovations Inc (Luna) is an optical technology development company that research, develops and commercializes speed optics and fiber optic test products. The company provides products such as fiber optic sensing products, fiber optic test and measurement products, high speed optical pr …
  • DaVita Inc (DVA)-医療機器分野:企業M&A・提携分析
    Summary DaVita Inc (DaVita), formerly DaVita HealthCare Partners Inc., is a provider of dialysis services and integrated health care delivery and management services. The company is a provider of dialysis services in the US for patients with chronic kidney failure and end-stage renal disease (ESRD). …
  • Veloxis Pharmaceuticals AS:企業の戦略的SWOT分析
    Veloxis Pharmaceuticals AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Dana Petroleum Ltd:企業の戦略的SWOT分析
    Dana Petroleum Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Pt Panorama Sentrawisata Tbk
    Pt Panorama Sentrawisata Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Panorama Sentrawisata Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • South Kentucky Rural Electric Cooperative Corp:企業の戦略的SWOT分析
    South Kentucky Rural Electric Cooperative Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Sunshine Oilsands Ltd (2012):企業の財務・戦略的SWOT分析
    Summary Sunshine Oilsands Ltd (Sunshine Oilsands) is an oil and gas company that develops holdings of oil sands and PN&G leases. The company owns and controls oil sands leases. Its properties include Thickwood, West Ells, Muskwa, Harper, Legend Lake and Portage, among others. Sunshine Oilsands also …
  • HomeWorks Tri-County Electric Cooperative Inc:発電所・企業SWOT分析
    HomeWorks Tri-County Electric Cooperative Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, in …
  • Fanhua Inc:企業のM&A・事業提携・投資動向
    Fanhua Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fanhua Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Camaieu:企業の戦略・SWOT・財務情報
    Camaieu - Strategy, SWOT and Corporate Finance Report Summary Camaieu - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Peptilogics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Peptilogics Inc (Peptilogics) is an early-stage biotechnology company that develops novel peptide therapeutics. The company’s antibiotics address the epidemic of multidrug-resistant bacterial infections. Its products portfolio includes engineered Cationic Antibiotic Peptides (eCAP) technolog …
  • Stobart Group Limited (STOB):企業の財務・戦略的SWOT分析
    Stobart Group Limited (STOB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Centre for Commercialization of Regenerative Medicine-製薬・医療分野:企業M&A・提携分析
    Summary Centre for Commercialization of Regenerative Medicine (CCRM) is an healthcare service provider that offers cell reprogramming and engineering, cell manufacturing, bio materials and devices manufacturing. The center’s cell reprogramming and engineering offers various capabilities such as esta …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆